Daebongls.Co.,Ltd. (KOSDAQ:078140)
8,240.00
-20.00 (-0.24%)
At close: Jun 10, 2026
Daebongls.Co.,Ltd. Revenue
Daebongls.Co.,Ltd. had revenue of 29.06B KRW in the quarter ending March 31, 2026, with 12.04% growth. This brings the company's revenue in the last twelve months to 105.19B, up 8.55% year-over-year. In the year 2025, Daebongls.Co.,Ltd. had annual revenue of 102.06B with 8.63% growth.
Revenue (ttm)
105.19B
Revenue Growth
+8.55%
P/S Ratio
0.87
Revenue / Employee
802.95M
Employees
131
Market Cap
91.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.06B | 8.11B | 8.63% |
| Dec 31, 2024 | 93.95B | 6.33B | 7.23% |
| Dec 31, 2023 | 87.62B | -5.88B | -6.29% |
| Dec 31, 2022 | 93.50B | 10.55B | 12.71% |
| Dec 31, 2021 | 82.96B | 6.70B | 8.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ecoplastic | 2.56T |
| Meta Biomed | 99.67B |
| Com2uS Holdings | 92.02B |
| OSTEONIC | 48.77B |
| Amicogen | 43.44B |
| 4by4 Inc | 34.27B |
| NFC Corporation | 34.07B |
| ISTE Co., Ltd. | 28.27B |